trial · primary record
KXV01 TCR Lentinvivo Injection
Advanced Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Dose-limiting Toxicity |
| Registry ID | NCT07275853 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:43.633Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07275853
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.